A prospective study of exosomal LncSENP6 for early warning of liver metastases in colorectal cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100051940

Enrollment

Unknown

Registered

2021-10-09

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Gold Standard:tissue or cytopathology

Index test:secreted LncRNA

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with colorectal cancer confirmed by tissue or cytopathology; 2.Have complete clinical and pathological data; 3.Aged over 18 years old.

Exclusion criteria

Exclusion criteria: 1.Preoperative chemotherapy or radiotherapy for colorectal cancer; 2.Non-lymph node and liver metastases from colorectal cancer; 3.Accompanied by hepatitis B virus, HIV virus and acute infection; 4.Patients with other tumors, chronic wasting diseases, metabolic diseases, or other malignant diseases.

Design outcomes

Primary

Measure	Time frame
Differential expression of LncRNA in peripheral blood exosomes of patients;	—

Countries

China

Contacts

Public ContactZhang Jian

The First Affiliated Hospital of the Air Force Medical University

biozhangj@fmmu.edu.cn+86 18149061689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026